<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2022-06-06</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-2748</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>Self-care as the Basis of the Mobile Application for Patients with Chronic Coronary Syndromes</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка способности к самопомощи как основа для мобильного приложения для пациентов со стабильной стенокардией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4322-8112</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ласкова</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Laskova</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ласкова Аксиния Игоревна - eLibrary SPIN 4117-9538.</p></bio><bio xml:lang="en"><p>Aksiniya I. Laskova - eLibrary SPIN 4117-9538.</p></bio><email xlink:type="simple">kabargina.a.i@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0389-560X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролов</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolov</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фролов Максим Юрьевич  - eLibrary SPIN 7585-1728.</p></bio><bio xml:lang="en"><p>Maxim Yu. Frolov - eLibrary SPIN 7585-1728.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4854-7462</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлова</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlova</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орлова Юлия Александровна – eLibrary SPIN 6663-1457.</p></bio><bio xml:lang="en"><p>Yulia A. Orlova - eLibrary SPIN 6663-1457.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8744-7144</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лопатин</surname><given-names>Ю. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lopatin</surname><given-names>Yu. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лопатин Юрий Михайлович - eLibrary SPIN 4850-3618.</p></bio><bio xml:lang="en"><p>Yury M. Lopatin - eLibrary SPIN 4850-3618.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Волгоградский государственный медицинский университет; Волгоградский областной клинический кардиологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volgograd State Medical University; Volgograd Regional Clinical Cardiology Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Волгоградский государственный медицинский университет; Ассоциация клинических фармакологов</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volgograd State Medical University; Association of clinical pharmacologists</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Волгоградский государственный технический университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volgograd State Technical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>06</day><month>07</month><year>2022</year></pub-date><volume>18</volume><issue>3</issue><fpage>268</fpage><lpage>273</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Laskova A.I., Frolov M.Y., Orlova Y.A., Lopatin Y.M., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Ласкова А.И., Фролов М.Ю., Орлова Ю.А., Лопатин Ю.М.</copyright-holder><copyright-holder xml:lang="en">Laskova A.I., Frolov M.Y., Orlova Y.A., Lopatin Y.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/2748">https://www.rpcardio.online/jour/article/view/2748</self-uri><abstract><sec><title>Aim</title><p>Aim. To evaluate the impact of a mobile application usage on the self-care skills, quality of life, adherence to treatment, as well as the psychological characteristics of comorbid patients with stable coronary heart disease.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study will include patients over 18 years of age with an established diagnosis of ischemic heart disease, exertional angina pectoris I-IV CCS functional class, who have the technical ability to use the mobile application "B2Doc: Angina" on their smartphone. This mobile application contains main components of recommendations for the management of coronary heart disease and monitoring of patient’s well-being. The program is based on the previously developed and validated questionnaire of the self-care ability of patients with coronary artery disease. The mobile application includes advice of the day, tracking the dynamics of angina pectoris symptoms, blood pressure and pulse, a medication diary as well as educational material about coronary heart disease. The study will assess quality of life: general (SF-36) and angina-related (Seattle Angina Questionnaire), self-care skills using the Self-Care of Coronary Heart Disease Inventory questionnaire. The primary endpoints will be cardiovascular events (cardiovascular death, acute myocardial infarction, acute cerebrovascular accident, hospitalization with unstable angina or decompensated chronic heart failure) and death from all causes. Endpoints will be evaluated in 1, 3, 6 and 12 months after discharge.</p></sec><sec><title>Expected results</title><p>Expected results. We expect that the use of the mobile application "B2Doc: Angina" by patients will improve their self-care skills and quality of life, as well as increase awareness of the disease.</p></sec><sec><title>Conclusions</title><p>Conclusions. The use of the newly developed mobile application "B2Doc: Angina" is a potential tool for the prevention and treatment of coronary heart disease. It represents a promising solution for the rapid implementation and expansion of telemedicine practice. </p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель. Оценить влияние использования мобильного приложения на способность к самопомощи, качество жизни, а также психологические характеристики коморбидных пациентов со стабильной ишемической болезнью сердца (ИБС).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В запланированное открытое параллельное контролируемое рандомизированное исследование будут включаться пациенты в старше 18 лет с установленным диагнозом «ИБС. Стенокардия напряжения I-IV функционального класса по классификации Канадской ассоциации кардиологов», имеющих техническую возможность использования мобильного приложения «B2Doc: Стенокардия» на своем смартфоне. Настоящее приложение содержит информационный (рекомендации по терапии ИБС и мониторингу самочувствия), обучающий и контролирующий (оценка АД, ЧСС, частоты приступов стенокардии) блоки. В исследовании будут оцениваться показатели качества жизни: общего (SF-36) и связанного со стенокардией напряжения (Seattle Angina Questionnaire), способность к самопомощи при помощи опросника Self-Care of Coronary Heart Disease Inventory. Первичными конечными точками станут сердечно-сосудистые события (сердечно-сосудистая смерть, острый инфаркт миокарда, острое нарушение мозгового кровообращения, госпитализация с нестабильной стенокардией или декомпенсацией хронической сердечной недостаточности), а также смерть от всех причин. Оценка конечных точек будет проводиться через 1, 3, 6 и 12 мес после выписки из стационара.</p></sec><sec><title>Планируемые результаты</title><p>Планируемые результаты. Ожидается, что использование пациентами мобильного приложения «B2Doc: Стенокардия» позволит повысить уровень их навыков самопомощи, улучшить приверженность лечению и качество жизни, а также повысит информированность о заболевании.</p></sec><sec><title>Заключение</title><p>Заключение. Использование разработанного мобильного приложения «B2Doc: Стенокардия» является потенциальным инструментом для профилактики и лечения ишемической болезни сердца, представляет собой многообещающее решение для быстрого внедрения и расширения телемедицинской практики.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>стабильная стенокардия</kwd><kwd>мобильное приложение</kwd><kwd>качество жизни</kwd><kwd>способность к самопомощи</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stable angina</kwd><kwd>mobile application</kwd><kwd>quality of life</kwd><kwd>self-care</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено при поддержке Волгоградского областного клинического кардиологического центра, Волгоградского государственного медицинского университета, Волгоградского государственного технического университета</funding-statement><funding-statement xml:lang="en">The study was performed with the support of the Volgograd Regional Clinical Cardiology Center, Volgograd State Medical University, Volgograd State Technical University</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Virani SS, Alonso A, Benjamin EJ, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139e596. DOI:10.1161/CIR.0000000000000757.</mixed-citation><mixed-citation xml:lang="en">Virani SS, Alonso A, Benjamin EJ, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139e596. DOI:10.1161/CIR.0000000000000757.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41(1):12-85. DOI:10.1093/eurheartj/ehz859.</mixed-citation><mixed-citation xml:lang="en">Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41(1):12-85. DOI:10.1093/eurheartj/ehz859.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412-24. DOI:10.1016/j.ahj.2011.06.007.</mixed-citation><mixed-citation xml:lang="en">Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412-24. DOI:10.1016/j.ahj.2011.06.007.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Strömberg A, Jaarsma T, Riegel B. Self-care: who cares? Eur J Cardiovasc Nurs. 2012;11(2):133-4. DOI:10.1177/1474515111429660.</mixed-citation><mixed-citation xml:lang="en">Strömberg A, Jaarsma T, Riegel B. Self-care: who cares? Eur J Cardiovasc Nurs. 2012;11(2):133-4. DOI:10.1177/1474515111429660.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Riegel B, Jaarsma T, Strömberg A. A middle-range theory of self-care of chronic illness. ANS Adv Nurs Sci. 2012;35(3):194-204. DOI:10.1097/ANS.0b013e318261b1ba.</mixed-citation><mixed-citation xml:lang="en">Riegel B, Jaarsma T, Strömberg A. A middle-range theory of self-care of chronic illness. ANS Adv Nurs Sci. 2012;35(3):194-204. DOI:10.1097/ANS.0b013e318261b1ba.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Riegel B, Jaarsma T, Strömberg A. A middle-range theory of self-care of chronic illness. ANS Adv Nurs Sci. 2012;35(3):194-204. DOI:10.1097/ANS.0b013e318261b1ba.</mixed-citation><mixed-citation xml:lang="en">Riegel B, Jaarsma T, Strömberg A. A middle-range theory of self-care of chronic illness. ANS Adv Nurs Sci. 2012;35(3):194-204. DOI:10.1097/ANS.0b013e318261b1ba.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli MF, Hoes AW, Agewall S, et al. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. DOI:10.1093/eurheartj/ehw106.</mixed-citation><mixed-citation xml:lang="en">Piepoli MF, Hoes AW, Agewall S, et al. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. DOI:10.1093/eurheartj/ehw106.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Saraste A, Knuuti J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging. Herz. 2020;45(5):409-20. DOI:10.1007/s00059-020-04935-x.</mixed-citation><mixed-citation xml:lang="en">Saraste A, Knuuti J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging. Herz. 2020;45(5):409-20. DOI:10.1007/s00059-020-04935-x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Beishuizen CR, Stephan BC, van Gool WA, et al. Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis. J Med Internet Res. 2016;18(3):e55. DOI:10.2196/jmir.5218.</mixed-citation><mixed-citation xml:lang="en">Beishuizen CR, Stephan BC, van Gool WA, et al. Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis. J Med Internet Res. 2016;18(3):e55. DOI:10.2196/jmir.5218.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Adler AJ, Martin N, Mariani J, et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;4(4):CD011851. DOI:10.1002/14651858.CD011851.pub2.</mixed-citation><mixed-citation xml:lang="en">Adler AJ, Martin N, Mariani J, et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;4(4):CD011851. DOI:10.1002/14651858.CD011851.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cajita MI, Gleason KT, Han HR. A Systematic Review of mHealth-Based Heart Failure Interventions. J Cardiovasc Nurs. 2016;31(3):E10-22. DOI:10.1097/JCN.0000000000000305.</mixed-citation><mixed-citation xml:lang="en">Cajita MI, Gleason KT, Han HR. A Systematic Review of mHealth-Based Heart Failure Interventions. J Cardiovasc Nurs. 2016;31(3):E10-22. DOI:10.1097/JCN.0000000000000305.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Гребенникова А.А., Столяров А.Ю., Лопатин Ю.М. Применение платформы удаленного мониторинга на базе мобильного приложения для повышения приверженности к самопомощи пациентов с хронической сердечной недостаточностью. Кардиология. 2017;57(4S):11-]8. DOI:10.18087/cardio.2413.</mixed-citation><mixed-citation xml:lang="en">Grebennikova AA, Stoliarov AU, Lopatin YuM. The use of platform for remote monitoring on the base of mobile app for improving self-care in patients with chronic heart failure. Kardiologiia. 2017;57(4S):11-8 (In Russ.) DOI:10.18087/cardio.2413.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Devi R, Singh SJ, Powell J, et al. Internet-based interventions for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2015;(12):CD009386. DOI:10.1002/14651858.CD009386.pub2.</mixed-citation><mixed-citation xml:lang="en">Devi R, Singh SJ, Powell J, et al. Internet-based interventions for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2015;(12):CD009386. DOI:10.1002/14651858.CD009386.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dorje T, Zhao G, Tso K, et al. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. Lancet Digit Health. 2019;1(7):e363-e374. DOI:10.1016/S2589-7500(19)30151-7.</mixed-citation><mixed-citation xml:lang="en">Dorje T, Zhao G, Tso K, et al. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. Lancet Digit Health. 2019;1(7):e363-e374. DOI:10.1016/S2589-7500(19)30151-7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Кабаргина А.И., Лопатин Ю.М. Валидность и надежность русскоязычной версии опросника способности к самопомощи “The Self-Care of Coronary Heart Disease Inventory” при хронических коронарных синдромах. Российский Кардиологический Журнал. 2020;25(9):3961. DOI:10.15829/1560-4071-2020-3961.</mixed-citation><mixed-citation xml:lang="en">Kabargina AI, Lopatin YuM. Validity and reliability of the Russian-language version of the Self-Care of Coronary Heart Disease Inventory in patients with chronic coronary syndromes. Russian Journal of Cardiology. 2020;25(9):3961 (In Russ.) DOI:10.15829/1560-4071-2020-3961.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Российское кардиологическое общество. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020. Российский Кардиологический Журнал. 2020;25(11):4076. DOI:10.15829/29/1560-4071-2020-4076.</mixed-citation><mixed-citation xml:lang="en">Russian Society of Cardiology. Stable ischemic heart disease. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(11):4076 (In Russ.) DOI:10.15829/29/1560-4071-2020-4076.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. DOI:10.1097/00005650-19860100000007.</mixed-citation><mixed-citation xml:lang="en">Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. DOI:10.1097/00005650-19860100000007.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kelli HM, Witbrodt B, Shah A. The future of mobile health applications and devices in cardiovascular health. Euro Med J Innov. 2017;2017:92-97. PMID: 28191545</mixed-citation><mixed-citation xml:lang="en">Kelli HM, Witbrodt B, Shah A. The future of mobile health applications and devices in cardiovascular health. Euro Med J Innov. 2017;2017:92-97. PMID: 28191545</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Dorje T, Zhao G, Tso K, et al. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. Lancet Digit Health. 2019;1(7):e363-e374. DOI:10.1016/S2589-7500(19)30151-7.</mixed-citation><mixed-citation xml:lang="en">Dorje T, Zhao G, Tso K, et al. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. Lancet Digit Health. 2019;1(7):e363-e374. DOI:10.1016/S2589-7500(19)30151-7.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
